Prenatal test (NIFTY)
About
NIFTY (Non-Invasive Fetal Trisomy) is a prenatal test used to detect fetal genetic abnormalities during pregnancy. This test utilizes next-generation sequencing (NGS) technology to analyze fetal DNA in the mother's blood.
Candidate
The NIFTY test is recommended for pregnant women who are at an increased risk of fetal genetic abnormalities, including women over the age of 35, those with a family history of genetic disorders, or those with increased risk identified by other screenings.
Preparation
There is no specific preparation required before testing. However, advice on diet and instructions from the doctor may be helpful to ensure the accuracy of the results.
Treatment
The NIFTY test involves taking a sample of the mother's blood, which is then sent to the laboratory for analysis. Fetal DNA is analyzed in the laboratory to detect possible genetic abnormalities.
Result
The results of the NIFTY test provide information on the presence or absence of certain genetic disorders or trisomies in the fetus, such as Down syndrome, Edwards syndrome, Patau syndrome, and others. These results help doctors assess the risk of genetic disorders and plan further monitoring of the pregnancy or treatment.
Precautions
It is important for the results of the NIFTY test to be interpreted by a qualified expert to ensure accuracy and provide adequate genetic counseling to the family. The results may require additional tests or further medical procedures, depending on the identified risks or the presence of genetic abnormalities.
F.A.Q.
NIPT is a prenatal screening method that analyzes fetal DNA present in the mother's blood to detect certain genetic conditions and chromosomal abnormalities.
NIFTY (Non-Invasive Fetal TrisomY test) is a brand of NIPT that focuses on screening for common chromosomal disorders such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13).
NIPT is a non-invasive method that requires only a blood sample from the pregnant woman. It has higher accuracy in detecting certain genetic conditions compared to traditional screening tests.
NIPT is typically performed after the 10th week of pregnancy. It's usually recommended for women with a higher risk of chromosomal abnormalities or as part of routine prenatal screening.
NIPT can detect common chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), and sometimes sex chromosome abnormalities.
NIPT has a high accuracy rate for the conditions it screens for, but it's important to understand that it's a screening test, not a diagnostic test. Positive results should be confirmed by further diagnostic testing.
Yes, NIPT is considered safe for both the baby and the mother as it involves only a blood draw from the mother.
Yes, in most cases NIPT can determine the baby's gender with a high degree of accuracy.
If your NIPT results are positive for a chromosomal abnormality, your healthcare provider will likely recommend further diagnostic tests, such as amniocentesis or chorionic villus sampling (CVS), to confirm the diagnosis.
Prenatal testing, such as NIPT, offers several benefits. It provides early detection of certain genetic conditions, allowing parents to make informed decisions about their pregnancy. It reduces the need for invasive procedures like amniocentesis or chorionic villus sampling (CVS) for diagnosis. NIPT also offers a higher detection rate and lower false positive rate compared to traditional screening tests.
Send an inquiry for the treatment
Start your way towards a successful treatment today. Fill out the form with your data, choose the service you need and we will connect you with the top medical experts in Zagreb.